BRIEF-Kimia Biosciences Gets Nod To Manufacture New API

  • Reuters
  • Stock Market News
BRIEF-Kimia Biosciences Gets Nod To Manufacture New API
Credit: © Reuters.

April 29 (Reuters) - Kimia Biosciences Ltd KIMI.BO :

* GRANTED PERMISSION TO MANUFACTURING AND MARKETING OF NEW ACTIVE PHARMACEUTICAL INGREDIENT AZELNIDIPINE DRUG

* PERMISSION BY INDIA'S CENTRAL DRUGS STANDARD CONTROL ORGANIZATION

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles